
### [NCIT:C8033](http://purl.obolibrary.org/obo/NCIT_C8033)
**Label:** Stage I Lip and Oral Cavity Cancer AJCC v6 and v7

**Subclasses:** [NCIT:C5876](http://purl.obolibrary.org/obo/NCIT_C5876) (Stage I Lip Cancer AJCC v6 and v7), [NCIT:C115057](http://purl.obolibrary.org/obo/NCIT_C115057) (Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C5883](http://purl.obolibrary.org/obo/NCIT_C5883) (Stage I Oral Cavity Cancer AJCC v6 and v7), [NCIT:C8199](http://purl.obolibrary.org/obo/NCIT_C8199) (Stage I Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7), [NCIT:C6053](http://purl.obolibrary.org/obo/NCIT_C6053) (Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8200](http://purl.obolibrary.org/obo/NCIT_C8200) (Stage I Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7), [NCIT:C8197](http://purl.obolibrary.org/obo/NCIT_C8197) (Stage I Lip Basal Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 53.57%
- [NCIT:C90529](http://purl.obolibrary.org/obo/NCIT_C90529) (AJCC v6 Stage) 53.57%
- [NCIT:C27966](http://purl.obolibrary.org/obo/NCIT_C27966) (Stage I) 53.57%
- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma))) 38.93%


